Vericel Corp
VCEL · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Mclaughlin Kevin F: Form 4
Insider disclosure · Filed · Report period 12 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- VCEL · 92346J108 - Common Stock, no par value per share
Company details and SEC sources
CIK 0000887359 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VCEL on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 25 Blue Sky Drive, Burlington, MA, 01803
- Incorporated in
- MI
- Fiscal year end
- 31 December
- Former names on EDGAR
- AASTROM BIOSCIENCES INC (to 14 Nov 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields